InvestorsHub Logo
Followers 25
Posts 2423
Boards Moderated 0
Alias Born 07/25/2013

Re: None

Saturday, 11/04/2017 5:54:37 AM

Saturday, November 04, 2017 5:54:37 AM

Post# of 345744
Miles for Mary research fundraiser to be held Nov. 6

Gerstner is the primary investigator for a new Phase II Clinical Trial of a treatment of glioblastoma with a combination of bavituximab, temozolomide and radiation therapy. She is also running a clinical trial exploring the use of a novel PET tracer that highlights inflammation (a desired response with immunotherapy) in the brain in order to tease out tumor response to immunotherapy.




http://marblehead.wickedlocal.com/news/20171103/miles-for-mary-research-fundraiser-to-be-held-nov-6

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News